We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

May 31, 2017

Janssen Biotech, Inc. v. Celltrion Healthcare Co., Ltd. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. July 31, 2018

    Janssen Loses Remicade Patent Case To Pfizer, Celltrion

    A recipe related to Janssen Biotech Inc.’s blockbuster immunosuppressant Remicade was too obvious for any competitor to have legally infringed a patent on it, a Massachusetts federal judge ruled Tuesday, allowing Pfizer Inc. to rest easy about the validity of its new-to-market equivalent to treat arthritis and psoriasis among other common conditions. 

6 other articles on this case. View all »

Parties

To view the parties, register now.